Clinical Trials Directory

Trials / Terminated

TerminatedNCT00642226

Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

A Randomized Study Comparing Combined Vitrectomy and Triamcinolone to Laser Grid in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Helse Stavanger HF · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether pars plana vitrectomy in combination with triamcinolone acetate is effective in the treatment of macular edema due to branch retinal vein occlusion.

Conditions

Interventions

TypeNameDescription
PROCEDUREGrid LaserETDRS Grid Laser
PROCEDUREVitrectomy and 20 mg triamcinolonePars plana vitrectomy is followed by an injection of 20 mg purified triamcinolone acetate

Timeline

Start date
2006-11-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2008-03-24
Last updated
2014-01-06

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00642226. Inclusion in this directory is not an endorsement.

Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO) (NCT00642226) · Clinical Trials Directory